nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprazolam—CYP2C9—Bexarotene—hematologic cancer	0.0263	0.0409	CbGbCtD
Alprazolam—CYP3A7—Ifosfamide—hematologic cancer	0.0246	0.0382	CbGbCtD
Alprazolam—CYP3A7-CYP3A51P—Ifosfamide—hematologic cancer	0.0246	0.0382	CbGbCtD
Alprazolam—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.0235	0.0365	CbGbCtD
Alprazolam—CYP3A7—Imatinib—hematologic cancer	0.0235	0.0365	CbGbCtD
Alprazolam—CYP3A5—Daunorubicin—hematologic cancer	0.023	0.0357	CbGbCtD
Alprazolam—CYP2C9—Idarubicin—hematologic cancer	0.0218	0.0339	CbGbCtD
Alprazolam—CYP3A5—Thalidomide—hematologic cancer	0.0209	0.0325	CbGbCtD
Alprazolam—CYP3A5—Teniposide—hematologic cancer	0.02	0.0311	CbGbCtD
Alprazolam—CYP3A5—Ifosfamide—hematologic cancer	0.0184	0.0287	CbGbCtD
Alprazolam—CYP3A5—Imatinib—hematologic cancer	0.0176	0.0274	CbGbCtD
Alprazolam—CYP2C9—Bortezomib—hematologic cancer	0.0161	0.0251	CbGbCtD
Alprazolam—CYP3A4—Bexarotene—hematologic cancer	0.0153	0.0238	CbGbCtD
Alprazolam—CYP3A7-CYP3A51P—Irinotecan—hematologic cancer	0.0147	0.0228	CbGbCtD
Alprazolam—CYP3A7—Irinotecan—hematologic cancer	0.0147	0.0228	CbGbCtD
Alprazolam—CYP3A4—Lomustine—hematologic cancer	0.0142	0.0221	CbGbCtD
Alprazolam—CYP3A4—Busulfan—hematologic cancer	0.0142	0.0221	CbGbCtD
Alprazolam—CYP3A5—Dasatinib—hematologic cancer	0.0141	0.022	CbGbCtD
Alprazolam—CYP2C9—Thalidomide—hematologic cancer	0.014	0.0218	CbGbCtD
Alprazolam—CYP2C9—Teniposide—hematologic cancer	0.0134	0.0208	CbGbCtD
Alprazolam—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.0128	0.0199	CbGbCtD
Alprazolam—CYP3A7—Vincristine—hematologic cancer	0.0128	0.0199	CbGbCtD
Alprazolam—CYP3A4—Thiotepa—hematologic cancer	0.0127	0.0197	CbGbCtD
Alprazolam—CYP2C9—Ifosfamide—hematologic cancer	0.0124	0.0192	CbGbCtD
Alprazolam—CYP2C9—Imatinib—hematologic cancer	0.0118	0.0184	CbGbCtD
Alprazolam—CYP3A5—Irinotecan—hematologic cancer	0.011	0.0171	CbGbCtD
Alprazolam—CYP2C9—Nilotinib—hematologic cancer	0.0107	0.0167	CbGbCtD
Alprazolam—CYP3A4—Methoxsalen—hematologic cancer	0.00985	0.0153	CbGbCtD
Alprazolam—CYP3A7—Dexamethasone—hematologic cancer	0.00966	0.015	CbGbCtD
Alprazolam—CYP3A7-CYP3A51P—Dexamethasone—hematologic cancer	0.00966	0.015	CbGbCtD
Alprazolam—CYP3A5—Vincristine—hematologic cancer	0.00961	0.0149	CbGbCtD
Alprazolam—CYP3A4—Bortezomib—hematologic cancer	0.00937	0.0146	CbGbCtD
Alprazolam—CYP3A4—Daunorubicin—hematologic cancer	0.00897	0.0139	CbGbCtD
Alprazolam—CYP3A5—Etoposide—hematologic cancer	0.00881	0.0137	CbGbCtD
Alprazolam—CYP3A4—Cytarabine—hematologic cancer	0.00791	0.0123	CbGbCtD
Alprazolam—CYP3A4—Teniposide—hematologic cancer	0.00779	0.0121	CbGbCtD
Alprazolam—CYP3A5—Dexamethasone—hematologic cancer	0.00724	0.0113	CbGbCtD
Alprazolam—CYP3A4—Ifosfamide—hematologic cancer	0.00719	0.0112	CbGbCtD
Alprazolam—CYP3A4—Imatinib—hematologic cancer	0.00687	0.0107	CbGbCtD
Alprazolam—CYP3A4—Ruxolitinib—hematologic cancer	0.00647	0.0101	CbGbCtD
Alprazolam—CYP3A4—Nilotinib—hematologic cancer	0.00624	0.0097	CbGbCtD
Alprazolam—CYP3A4—Vinorelbine—hematologic cancer	0.00619	0.00962	CbGbCtD
Alprazolam—CYP2C9—Cisplatin—hematologic cancer	0.00601	0.00935	CbGbCtD
Alprazolam—CYP3A4—Triamcinolone—hematologic cancer	0.00566	0.0088	CbGbCtD
Alprazolam—CYP3A4—Dasatinib—hematologic cancer	0.00552	0.00857	CbGbCtD
Alprazolam—CYP3A4—Mitoxantrone—hematologic cancer	0.00545	0.00847	CbGbCtD
Alprazolam—CYP2C9—Dexamethasone—hematologic cancer	0.00486	0.00755	CbGbCtD
Alprazolam—CYP3A4—Betamethasone—hematologic cancer	0.00486	0.00755	CbGbCtD
Alprazolam—CYP3A4—Prednisolone—hematologic cancer	0.00479	0.00745	CbGbCtD
Alprazolam—CYP3A4—Prednisone—hematologic cancer	0.00452	0.00703	CbGbCtD
Alprazolam—CYP3A4—Irinotecan—hematologic cancer	0.00429	0.00667	CbGbCtD
Alprazolam—CYP3A4—Vinblastine—hematologic cancer	0.00381	0.00593	CbGbCtD
Alprazolam—CYP3A4—Vincristine—hematologic cancer	0.00375	0.00583	CbGbCtD
Alprazolam—CYP3A4—Etoposide—hematologic cancer	0.00344	0.00534	CbGbCtD
Alprazolam—CYP3A4—Dexamethasone—hematologic cancer	0.00282	0.00439	CbGbCtD
Alprazolam—CYP3A4—Doxorubicin—hematologic cancer	0.00234	0.00364	CbGbCtD
Alprazolam—Flunitrazepam—UGT1A1—hematologic cancer	0.000179	0.265	CrCbGaD
Alprazolam—Midazolam—SLC22A1—hematologic cancer	0.000107	0.158	CrCbGaD
Alprazolam—Ketazolam—ALB—hematologic cancer	6.79e-05	0.1	CrCbGaD
Alprazolam—Ketazolam—ABCB1—hematologic cancer	6.48e-05	0.0957	CrCbGaD
Alprazolam—Clonazepam—ALB—hematologic cancer	5.48e-05	0.0808	CrCbGaD
Alprazolam—Clobazam—ABCB1—hematologic cancer	4.58e-05	0.0676	CrCbGaD
Alprazolam—Nitrazepam—ABCB1—hematologic cancer	3.79e-05	0.0559	CrCbGaD
Alprazolam—Gastrointestinal disorder—Betamethasone—hematologic cancer	3.47e-05	0.000109	CcSEcCtD
Alprazolam—Back pain—Methotrexate—hematologic cancer	3.47e-05	0.000109	CcSEcCtD
Alprazolam—Fatigue—Dexamethasone—hematologic cancer	3.47e-05	0.000109	CcSEcCtD
Alprazolam—Fatigue—Betamethasone—hematologic cancer	3.47e-05	0.000109	CcSEcCtD
Alprazolam—Chills—Epirubicin—hematologic cancer	3.46e-05	0.000108	CcSEcCtD
Alprazolam—Pruritus—Etoposide—hematologic cancer	3.46e-05	0.000108	CcSEcCtD
Alprazolam—Shock—Prednisone—hematologic cancer	3.45e-05	0.000108	CcSEcCtD
Alprazolam—Nervous system disorder—Prednisone—hematologic cancer	3.44e-05	0.000108	CcSEcCtD
Alprazolam—Tachycardia—Prednisone—hematologic cancer	3.42e-05	0.000107	CcSEcCtD
Alprazolam—Skin disorder—Prednisone—hematologic cancer	3.4e-05	0.000107	CcSEcCtD
Alprazolam—Nausea—Gemcitabine—hematologic cancer	3.4e-05	0.000106	CcSEcCtD
Alprazolam—Vomiting—Cisplatin—hematologic cancer	3.39e-05	0.000106	CcSEcCtD
Alprazolam—Hyperhidrosis—Prednisone—hematologic cancer	3.39e-05	0.000106	CcSEcCtD
Alprazolam—Vision blurred—Methotrexate—hematologic cancer	3.38e-05	0.000106	CcSEcCtD
Alprazolam—Mental disorder—Epirubicin—hematologic cancer	3.38e-05	0.000106	CcSEcCtD
Alprazolam—Erythema multiforme—Doxorubicin—hematologic cancer	3.38e-05	0.000106	CcSEcCtD
Alprazolam—Flurazepam—ABCB1—hematologic cancer	3.37e-05	0.0497	CrCbGaD
Alprazolam—Rash—Cisplatin—hematologic cancer	3.37e-05	0.000105	CcSEcCtD
Alprazolam—Dermatitis—Cisplatin—hematologic cancer	3.36e-05	0.000105	CcSEcCtD
Alprazolam—Malnutrition—Epirubicin—hematologic cancer	3.36e-05	0.000105	CcSEcCtD
Alprazolam—Diarrhoea—Etoposide—hematologic cancer	3.35e-05	0.000105	CcSEcCtD
Alprazolam—Anorexia—Prednisone—hematologic cancer	3.34e-05	0.000105	CcSEcCtD
Alprazolam—Eye disorder—Doxorubicin—hematologic cancer	3.34e-05	0.000104	CcSEcCtD
Alprazolam—Ill-defined disorder—Methotrexate—hematologic cancer	3.33e-05	0.000104	CcSEcCtD
Alprazolam—Tinnitus—Doxorubicin—hematologic cancer	3.33e-05	0.000104	CcSEcCtD
Alprazolam—Feeling abnormal—Dexamethasone—hematologic cancer	3.32e-05	0.000104	CcSEcCtD
Alprazolam—Feeling abnormal—Betamethasone—hematologic cancer	3.32e-05	0.000104	CcSEcCtD
Alprazolam—Cardiac disorder—Doxorubicin—hematologic cancer	3.31e-05	0.000104	CcSEcCtD
Alprazolam—Tension—Epirubicin—hematologic cancer	3.3e-05	0.000103	CcSEcCtD
Alprazolam—Gastrointestinal pain—Betamethasone—hematologic cancer	3.29e-05	0.000103	CcSEcCtD
Alprazolam—Gastrointestinal pain—Dexamethasone—hematologic cancer	3.29e-05	0.000103	CcSEcCtD
Alprazolam—Hypersensitivity—Triamcinolone—hematologic cancer	3.27e-05	0.000102	CcSEcCtD
Alprazolam—Nervousness—Epirubicin—hematologic cancer	3.26e-05	0.000102	CcSEcCtD
Alprazolam—Back pain—Epirubicin—hematologic cancer	3.25e-05	0.000102	CcSEcCtD
Alprazolam—Angiopathy—Doxorubicin—hematologic cancer	3.24e-05	0.000101	CcSEcCtD
Alprazolam—Malaise—Methotrexate—hematologic cancer	3.24e-05	0.000101	CcSEcCtD
Alprazolam—Dizziness—Etoposide—hematologic cancer	3.23e-05	0.000101	CcSEcCtD
Alprazolam—Muscle spasms—Epirubicin—hematologic cancer	3.23e-05	0.000101	CcSEcCtD
Alprazolam—Vertigo—Methotrexate—hematologic cancer	3.22e-05	0.000101	CcSEcCtD
Alprazolam—Mediastinal disorder—Doxorubicin—hematologic cancer	3.22e-05	0.000101	CcSEcCtD
Alprazolam—Chills—Doxorubicin—hematologic cancer	3.2e-05	0.0001	CcSEcCtD
Alprazolam—Urticaria—Betamethasone—hematologic cancer	3.2e-05	0.0001	CcSEcCtD
Alprazolam—Urticaria—Dexamethasone—hematologic cancer	3.2e-05	0.0001	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Prednisone—hematologic cancer	3.19e-05	9.99e-05	CcSEcCtD
Alprazolam—Dizziness—Prednisolone—hematologic cancer	3.19e-05	9.98e-05	CcSEcCtD
Alprazolam—Asthenia—Triamcinolone—hematologic cancer	3.18e-05	9.96e-05	CcSEcCtD
Alprazolam—Body temperature increased—Betamethasone—hematologic cancer	3.18e-05	9.95e-05	CcSEcCtD
Alprazolam—Abdominal pain—Betamethasone—hematologic cancer	3.18e-05	9.95e-05	CcSEcCtD
Alprazolam—Abdominal pain—Dexamethasone—hematologic cancer	3.18e-05	9.95e-05	CcSEcCtD
Alprazolam—Body temperature increased—Dexamethasone—hematologic cancer	3.18e-05	9.95e-05	CcSEcCtD
Alprazolam—Nausea—Cisplatin—hematologic cancer	3.17e-05	9.92e-05	CcSEcCtD
Alprazolam—Insomnia—Prednisone—hematologic cancer	3.17e-05	9.92e-05	CcSEcCtD
Alprazolam—Vision blurred—Epirubicin—hematologic cancer	3.17e-05	9.9e-05	CcSEcCtD
Alprazolam—Paraesthesia—Prednisone—hematologic cancer	3.15e-05	9.85e-05	CcSEcCtD
Alprazolam—Pruritus—Triamcinolone—hematologic cancer	3.14e-05	9.82e-05	CcSEcCtD
Alprazolam—Mental disorder—Doxorubicin—hematologic cancer	3.13e-05	9.79e-05	CcSEcCtD
Alprazolam—Midazolam—ABCB1—hematologic cancer	3.12e-05	0.0461	CrCbGaD
Alprazolam—Ill-defined disorder—Epirubicin—hematologic cancer	3.12e-05	9.75e-05	CcSEcCtD
Alprazolam—Convulsion—Methotrexate—hematologic cancer	3.11e-05	9.73e-05	CcSEcCtD
Alprazolam—Vomiting—Etoposide—hematologic cancer	3.11e-05	9.73e-05	CcSEcCtD
Alprazolam—Malnutrition—Doxorubicin—hematologic cancer	3.11e-05	9.72e-05	CcSEcCtD
Alprazolam—Agitation—Epirubicin—hematologic cancer	3.09e-05	9.66e-05	CcSEcCtD
Alprazolam—Dyspepsia—Prednisone—hematologic cancer	3.09e-05	9.65e-05	CcSEcCtD
Alprazolam—Rash—Etoposide—hematologic cancer	3.08e-05	9.65e-05	CcSEcCtD
Alprazolam—Dermatitis—Etoposide—hematologic cancer	3.08e-05	9.64e-05	CcSEcCtD
Alprazolam—Headache—Etoposide—hematologic cancer	3.06e-05	9.59e-05	CcSEcCtD
Alprazolam—Arthralgia—Methotrexate—hematologic cancer	3.06e-05	9.56e-05	CcSEcCtD
Alprazolam—Chest pain—Methotrexate—hematologic cancer	3.06e-05	9.56e-05	CcSEcCtD
Alprazolam—Myalgia—Methotrexate—hematologic cancer	3.06e-05	9.56e-05	CcSEcCtD
Alprazolam—Tension—Doxorubicin—hematologic cancer	3.05e-05	9.54e-05	CcSEcCtD
Alprazolam—Decreased appetite—Prednisone—hematologic cancer	3.05e-05	9.53e-05	CcSEcCtD
Alprazolam—Rash—Prednisolone—hematologic cancer	3.04e-05	9.52e-05	CcSEcCtD
Alprazolam—Dermatitis—Prednisolone—hematologic cancer	3.04e-05	9.51e-05	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	3.03e-05	9.49e-05	CcSEcCtD
Alprazolam—Malaise—Epirubicin—hematologic cancer	3.03e-05	9.48e-05	CcSEcCtD
Alprazolam—Fatigue—Prednisone—hematologic cancer	3.02e-05	9.45e-05	CcSEcCtD
Alprazolam—Headache—Prednisolone—hematologic cancer	3.02e-05	9.45e-05	CcSEcCtD
Alprazolam—Discomfort—Methotrexate—hematologic cancer	3.02e-05	9.45e-05	CcSEcCtD
Alprazolam—Nervousness—Doxorubicin—hematologic cancer	3.02e-05	9.44e-05	CcSEcCtD
Alprazolam—Vertigo—Epirubicin—hematologic cancer	3.02e-05	9.44e-05	CcSEcCtD
Alprazolam—Syncope—Epirubicin—hematologic cancer	3.01e-05	9.42e-05	CcSEcCtD
Alprazolam—Back pain—Doxorubicin—hematologic cancer	3.01e-05	9.41e-05	CcSEcCtD
Alprazolam—Constipation—Prednisone—hematologic cancer	3e-05	9.38e-05	CcSEcCtD
Alprazolam—Muscle spasms—Doxorubicin—hematologic cancer	2.99e-05	9.35e-05	CcSEcCtD
Alprazolam—Palpitations—Epirubicin—hematologic cancer	2.97e-05	9.29e-05	CcSEcCtD
Alprazolam—Confusional state—Methotrexate—hematologic cancer	2.95e-05	9.24e-05	CcSEcCtD
Alprazolam—Loss of consciousness—Epirubicin—hematologic cancer	2.95e-05	9.24e-05	CcSEcCtD
Alprazolam—Dizziness—Triamcinolone—hematologic cancer	2.93e-05	9.18e-05	CcSEcCtD
Alprazolam—Vision blurred—Doxorubicin—hematologic cancer	2.93e-05	9.16e-05	CcSEcCtD
Alprazolam—Convulsion—Epirubicin—hematologic cancer	2.91e-05	9.11e-05	CcSEcCtD
Alprazolam—Infection—Methotrexate—hematologic cancer	2.91e-05	9.11e-05	CcSEcCtD
Alprazolam—Nausea—Etoposide—hematologic cancer	2.9e-05	9.09e-05	CcSEcCtD
Alprazolam—Feeling abnormal—Prednisone—hematologic cancer	2.89e-05	9.04e-05	CcSEcCtD
Alprazolam—Asthenia—Dexamethasone—hematologic cancer	2.89e-05	9.03e-05	CcSEcCtD
Alprazolam—Asthenia—Betamethasone—hematologic cancer	2.89e-05	9.03e-05	CcSEcCtD
Alprazolam—Ill-defined disorder—Doxorubicin—hematologic cancer	2.88e-05	9.02e-05	CcSEcCtD
Alprazolam—Nervous system disorder—Methotrexate—hematologic cancer	2.87e-05	8.99e-05	CcSEcCtD
Alprazolam—Gastrointestinal pain—Prednisone—hematologic cancer	2.87e-05	8.97e-05	CcSEcCtD
Alprazolam—Nausea—Prednisolone—hematologic cancer	2.86e-05	8.96e-05	CcSEcCtD
Alprazolam—Arthralgia—Epirubicin—hematologic cancer	2.86e-05	8.95e-05	CcSEcCtD
Alprazolam—Chest pain—Epirubicin—hematologic cancer	2.86e-05	8.95e-05	CcSEcCtD
Alprazolam—Myalgia—Epirubicin—hematologic cancer	2.86e-05	8.95e-05	CcSEcCtD
Alprazolam—Agitation—Doxorubicin—hematologic cancer	2.86e-05	8.94e-05	CcSEcCtD
Alprazolam—Anxiety—Epirubicin—hematologic cancer	2.85e-05	8.92e-05	CcSEcCtD
Alprazolam—Pruritus—Dexamethasone—hematologic cancer	2.85e-05	8.91e-05	CcSEcCtD
Alprazolam—Pruritus—Betamethasone—hematologic cancer	2.85e-05	8.91e-05	CcSEcCtD
Alprazolam—Skin disorder—Methotrexate—hematologic cancer	2.85e-05	8.9e-05	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	2.84e-05	8.89e-05	CcSEcCtD
Alprazolam—Hyperhidrosis—Methotrexate—hematologic cancer	2.83e-05	8.86e-05	CcSEcCtD
Alprazolam—Discomfort—Epirubicin—hematologic cancer	2.83e-05	8.84e-05	CcSEcCtD
Alprazolam—Vomiting—Triamcinolone—hematologic cancer	2.82e-05	8.82e-05	CcSEcCtD
Alprazolam—Diazepam—ALB—hematologic cancer	2.8e-05	0.0414	CrCbGaD
Alprazolam—Malaise—Doxorubicin—hematologic cancer	2.8e-05	8.77e-05	CcSEcCtD
Alprazolam—Rash—Triamcinolone—hematologic cancer	2.8e-05	8.75e-05	CcSEcCtD
Alprazolam—Dry mouth—Epirubicin—hematologic cancer	2.8e-05	8.75e-05	CcSEcCtD
Alprazolam—Dermatitis—Triamcinolone—hematologic cancer	2.79e-05	8.74e-05	CcSEcCtD
Alprazolam—Vertigo—Doxorubicin—hematologic cancer	2.79e-05	8.74e-05	CcSEcCtD
Alprazolam—Anorexia—Methotrexate—hematologic cancer	2.79e-05	8.74e-05	CcSEcCtD
Alprazolam—Syncope—Doxorubicin—hematologic cancer	2.79e-05	8.72e-05	CcSEcCtD
Alprazolam—Urticaria—Prednisone—hematologic cancer	2.78e-05	8.71e-05	CcSEcCtD
Alprazolam—Headache—Triamcinolone—hematologic cancer	2.78e-05	8.69e-05	CcSEcCtD
Alprazolam—Abdominal pain—Prednisone—hematologic cancer	2.77e-05	8.67e-05	CcSEcCtD
Alprazolam—Body temperature increased—Prednisone—hematologic cancer	2.77e-05	8.67e-05	CcSEcCtD
Alprazolam—Confusional state—Epirubicin—hematologic cancer	2.76e-05	8.65e-05	CcSEcCtD
Alprazolam—Diarrhoea—Dexamethasone—hematologic cancer	2.75e-05	8.62e-05	CcSEcCtD
Alprazolam—Diarrhoea—Betamethasone—hematologic cancer	2.75e-05	8.62e-05	CcSEcCtD
Alprazolam—Palpitations—Doxorubicin—hematologic cancer	2.75e-05	8.59e-05	CcSEcCtD
Alprazolam—Oedema—Epirubicin—hematologic cancer	2.74e-05	8.58e-05	CcSEcCtD
Alprazolam—Hypotension—Methotrexate—hematologic cancer	2.74e-05	8.56e-05	CcSEcCtD
Alprazolam—Loss of consciousness—Doxorubicin—hematologic cancer	2.73e-05	8.55e-05	CcSEcCtD
Alprazolam—Infection—Epirubicin—hematologic cancer	2.72e-05	8.52e-05	CcSEcCtD
Alprazolam—Shock—Epirubicin—hematologic cancer	2.7e-05	8.44e-05	CcSEcCtD
Alprazolam—Convulsion—Doxorubicin—hematologic cancer	2.69e-05	8.43e-05	CcSEcCtD
Alprazolam—Nervous system disorder—Epirubicin—hematologic cancer	2.69e-05	8.41e-05	CcSEcCtD
Alprazolam—Diazepam—ABCB1—hematologic cancer	2.68e-05	0.0395	CrCbGaD
Alprazolam—Tachycardia—Epirubicin—hematologic cancer	2.68e-05	8.37e-05	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.67e-05	8.35e-05	CcSEcCtD
Alprazolam—Skin disorder—Epirubicin—hematologic cancer	2.66e-05	8.33e-05	CcSEcCtD
Alprazolam—Dizziness—Betamethasone—hematologic cancer	2.66e-05	8.33e-05	CcSEcCtD
Alprazolam—Dizziness—Dexamethasone—hematologic cancer	2.66e-05	8.33e-05	CcSEcCtD
Alprazolam—Hyperhidrosis—Epirubicin—hematologic cancer	2.65e-05	8.29e-05	CcSEcCtD
Alprazolam—Insomnia—Methotrexate—hematologic cancer	2.65e-05	8.29e-05	CcSEcCtD
Alprazolam—Chest pain—Doxorubicin—hematologic cancer	2.65e-05	8.28e-05	CcSEcCtD
Alprazolam—Arthralgia—Doxorubicin—hematologic cancer	2.65e-05	8.28e-05	CcSEcCtD
Alprazolam—Myalgia—Doxorubicin—hematologic cancer	2.65e-05	8.28e-05	CcSEcCtD
Alprazolam—Anxiety—Doxorubicin—hematologic cancer	2.64e-05	8.25e-05	CcSEcCtD
Alprazolam—Nausea—Triamcinolone—hematologic cancer	2.63e-05	8.24e-05	CcSEcCtD
Alprazolam—Paraesthesia—Methotrexate—hematologic cancer	2.63e-05	8.23e-05	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	2.63e-05	8.22e-05	CcSEcCtD
Alprazolam—Discomfort—Doxorubicin—hematologic cancer	2.61e-05	8.18e-05	CcSEcCtD
Alprazolam—Anorexia—Epirubicin—hematologic cancer	2.61e-05	8.18e-05	CcSEcCtD
Alprazolam—Dyspnoea—Methotrexate—hematologic cancer	2.61e-05	8.17e-05	CcSEcCtD
Alprazolam—Somnolence—Methotrexate—hematologic cancer	2.6e-05	8.15e-05	CcSEcCtD
Alprazolam—Dry mouth—Doxorubicin—hematologic cancer	2.59e-05	8.1e-05	CcSEcCtD
Alprazolam—Hypersensitivity—Prednisone—hematologic cancer	2.58e-05	8.08e-05	CcSEcCtD
Alprazolam—Dyspepsia—Methotrexate—hematologic cancer	2.58e-05	8.07e-05	CcSEcCtD
Alprazolam—Hypotension—Epirubicin—hematologic cancer	2.56e-05	8.01e-05	CcSEcCtD
Alprazolam—Vomiting—Dexamethasone—hematologic cancer	2.56e-05	8.01e-05	CcSEcCtD
Alprazolam—Vomiting—Betamethasone—hematologic cancer	2.56e-05	8.01e-05	CcSEcCtD
Alprazolam—Confusional state—Doxorubicin—hematologic cancer	2.56e-05	8e-05	CcSEcCtD
Alprazolam—Decreased appetite—Methotrexate—hematologic cancer	2.55e-05	7.97e-05	CcSEcCtD
Alprazolam—Rash—Betamethasone—hematologic cancer	2.54e-05	7.94e-05	CcSEcCtD
Alprazolam—Rash—Dexamethasone—hematologic cancer	2.54e-05	7.94e-05	CcSEcCtD
Alprazolam—Oedema—Doxorubicin—hematologic cancer	2.54e-05	7.94e-05	CcSEcCtD
Alprazolam—Dermatitis—Betamethasone—hematologic cancer	2.54e-05	7.93e-05	CcSEcCtD
Alprazolam—Dermatitis—Dexamethasone—hematologic cancer	2.54e-05	7.93e-05	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.53e-05	7.91e-05	CcSEcCtD
Alprazolam—Fatigue—Methotrexate—hematologic cancer	2.53e-05	7.9e-05	CcSEcCtD
Alprazolam—Headache—Betamethasone—hematologic cancer	2.52e-05	7.89e-05	CcSEcCtD
Alprazolam—Headache—Dexamethasone—hematologic cancer	2.52e-05	7.89e-05	CcSEcCtD
Alprazolam—Infection—Doxorubicin—hematologic cancer	2.52e-05	7.88e-05	CcSEcCtD
Alprazolam—Asthenia—Prednisone—hematologic cancer	2.51e-05	7.87e-05	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.5e-05	7.81e-05	CcSEcCtD
Alprazolam—Shock—Doxorubicin—hematologic cancer	2.5e-05	7.81e-05	CcSEcCtD
Alprazolam—Nervous system disorder—Doxorubicin—hematologic cancer	2.49e-05	7.78e-05	CcSEcCtD
Alprazolam—Pruritus—Prednisone—hematologic cancer	2.48e-05	7.76e-05	CcSEcCtD
Alprazolam—Insomnia—Epirubicin—hematologic cancer	2.48e-05	7.76e-05	CcSEcCtD
Alprazolam—Tachycardia—Doxorubicin—hematologic cancer	2.48e-05	7.75e-05	CcSEcCtD
Alprazolam—Skin disorder—Doxorubicin—hematologic cancer	2.46e-05	7.71e-05	CcSEcCtD
Alprazolam—Paraesthesia—Epirubicin—hematologic cancer	2.46e-05	7.7e-05	CcSEcCtD
Alprazolam—Hyperhidrosis—Doxorubicin—hematologic cancer	2.45e-05	7.67e-05	CcSEcCtD
Alprazolam—Dyspnoea—Epirubicin—hematologic cancer	2.44e-05	7.65e-05	CcSEcCtD
Alprazolam—Somnolence—Epirubicin—hematologic cancer	2.44e-05	7.62e-05	CcSEcCtD
Alprazolam—Anorexia—Doxorubicin—hematologic cancer	2.42e-05	7.56e-05	CcSEcCtD
Alprazolam—Feeling abnormal—Methotrexate—hematologic cancer	2.41e-05	7.55e-05	CcSEcCtD
Alprazolam—Dyspepsia—Epirubicin—hematologic cancer	2.41e-05	7.55e-05	CcSEcCtD
Alprazolam—Diarrhoea—Prednisone—hematologic cancer	2.4e-05	7.5e-05	CcSEcCtD
Alprazolam—Gastrointestinal pain—Methotrexate—hematologic cancer	2.4e-05	7.49e-05	CcSEcCtD
Alprazolam—Nausea—Betamethasone—hematologic cancer	2.39e-05	7.48e-05	CcSEcCtD
Alprazolam—Nausea—Dexamethasone—hematologic cancer	2.39e-05	7.48e-05	CcSEcCtD
Alprazolam—Decreased appetite—Epirubicin—hematologic cancer	2.38e-05	7.46e-05	CcSEcCtD
Alprazolam—Hypotension—Doxorubicin—hematologic cancer	2.37e-05	7.42e-05	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.37e-05	7.4e-05	CcSEcCtD
Alprazolam—Fatigue—Epirubicin—hematologic cancer	2.36e-05	7.39e-05	CcSEcCtD
Alprazolam—Constipation—Epirubicin—hematologic cancer	2.34e-05	7.33e-05	CcSEcCtD
Alprazolam—Urticaria—Methotrexate—hematologic cancer	2.33e-05	7.28e-05	CcSEcCtD
Alprazolam—Dizziness—Prednisone—hematologic cancer	2.32e-05	7.25e-05	CcSEcCtD
Alprazolam—Abdominal pain—Methotrexate—hematologic cancer	2.32e-05	7.25e-05	CcSEcCtD
Alprazolam—Body temperature increased—Methotrexate—hematologic cancer	2.32e-05	7.25e-05	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.31e-05	7.23e-05	CcSEcCtD
Alprazolam—Insomnia—Doxorubicin—hematologic cancer	2.29e-05	7.18e-05	CcSEcCtD
Alprazolam—Paraesthesia—Doxorubicin—hematologic cancer	2.28e-05	7.13e-05	CcSEcCtD
Alprazolam—Dyspnoea—Doxorubicin—hematologic cancer	2.26e-05	7.08e-05	CcSEcCtD
Alprazolam—Feeling abnormal—Epirubicin—hematologic cancer	2.26e-05	7.07e-05	CcSEcCtD
Alprazolam—Somnolence—Doxorubicin—hematologic cancer	2.25e-05	7.06e-05	CcSEcCtD
Alprazolam—Gastrointestinal pain—Epirubicin—hematologic cancer	2.24e-05	7.01e-05	CcSEcCtD
Alprazolam—Dyspepsia—Doxorubicin—hematologic cancer	2.23e-05	6.99e-05	CcSEcCtD
Alprazolam—Vomiting—Prednisone—hematologic cancer	2.23e-05	6.97e-05	CcSEcCtD
Alprazolam—Rash—Prednisone—hematologic cancer	2.21e-05	6.91e-05	CcSEcCtD
Alprazolam—Dermatitis—Prednisone—hematologic cancer	2.21e-05	6.91e-05	CcSEcCtD
Alprazolam—Decreased appetite—Doxorubicin—hematologic cancer	2.2e-05	6.9e-05	CcSEcCtD
Alprazolam—Headache—Prednisone—hematologic cancer	2.2e-05	6.87e-05	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Doxorubicin—hematologic cancer	2.19e-05	6.85e-05	CcSEcCtD
Alprazolam—Fatigue—Doxorubicin—hematologic cancer	2.19e-05	6.84e-05	CcSEcCtD
Alprazolam—Urticaria—Epirubicin—hematologic cancer	2.18e-05	6.81e-05	CcSEcCtD
Alprazolam—Constipation—Doxorubicin—hematologic cancer	2.17e-05	6.79e-05	CcSEcCtD
Alprazolam—Abdominal pain—Epirubicin—hematologic cancer	2.17e-05	6.78e-05	CcSEcCtD
Alprazolam—Body temperature increased—Epirubicin—hematologic cancer	2.17e-05	6.78e-05	CcSEcCtD
Alprazolam—Hypersensitivity—Methotrexate—hematologic cancer	2.16e-05	6.75e-05	CcSEcCtD
Alprazolam—Asthenia—Methotrexate—hematologic cancer	2.1e-05	6.58e-05	CcSEcCtD
Alprazolam—Feeling abnormal—Doxorubicin—hematologic cancer	2.09e-05	6.54e-05	CcSEcCtD
Alprazolam—Nausea—Prednisone—hematologic cancer	2.08e-05	6.51e-05	CcSEcCtD
Alprazolam—Gastrointestinal pain—Doxorubicin—hematologic cancer	2.07e-05	6.49e-05	CcSEcCtD
Alprazolam—Pruritus—Methotrexate—hematologic cancer	2.07e-05	6.48e-05	CcSEcCtD
Alprazolam—Hypersensitivity—Epirubicin—hematologic cancer	2.02e-05	6.32e-05	CcSEcCtD
Alprazolam—Urticaria—Doxorubicin—hematologic cancer	2.01e-05	6.3e-05	CcSEcCtD
Alprazolam—Abdominal pain—Doxorubicin—hematologic cancer	2.01e-05	6.27e-05	CcSEcCtD
Alprazolam—Body temperature increased—Doxorubicin—hematologic cancer	2.01e-05	6.27e-05	CcSEcCtD
Alprazolam—Diarrhoea—Methotrexate—hematologic cancer	2e-05	6.27e-05	CcSEcCtD
Alprazolam—Asthenia—Epirubicin—hematologic cancer	1.97e-05	6.15e-05	CcSEcCtD
Alprazolam—Pruritus—Epirubicin—hematologic cancer	1.94e-05	6.07e-05	CcSEcCtD
Alprazolam—Dizziness—Methotrexate—hematologic cancer	1.94e-05	6.06e-05	CcSEcCtD
Alprazolam—Diarrhoea—Epirubicin—hematologic cancer	1.88e-05	5.87e-05	CcSEcCtD
Alprazolam—Hypersensitivity—Doxorubicin—hematologic cancer	1.87e-05	5.85e-05	CcSEcCtD
Alprazolam—Vomiting—Methotrexate—hematologic cancer	1.86e-05	5.83e-05	CcSEcCtD
Alprazolam—Rash—Methotrexate—hematologic cancer	1.85e-05	5.78e-05	CcSEcCtD
Alprazolam—Dermatitis—Methotrexate—hematologic cancer	1.85e-05	5.77e-05	CcSEcCtD
Alprazolam—Headache—Methotrexate—hematologic cancer	1.83e-05	5.74e-05	CcSEcCtD
Alprazolam—Asthenia—Doxorubicin—hematologic cancer	1.82e-05	5.69e-05	CcSEcCtD
Alprazolam—Dizziness—Epirubicin—hematologic cancer	1.81e-05	5.67e-05	CcSEcCtD
Alprazolam—Pruritus—Doxorubicin—hematologic cancer	1.79e-05	5.61e-05	CcSEcCtD
Alprazolam—Vomiting—Epirubicin—hematologic cancer	1.74e-05	5.45e-05	CcSEcCtD
Alprazolam—Nausea—Methotrexate—hematologic cancer	1.74e-05	5.44e-05	CcSEcCtD
Alprazolam—Diarrhoea—Doxorubicin—hematologic cancer	1.74e-05	5.43e-05	CcSEcCtD
Alprazolam—Rash—Epirubicin—hematologic cancer	1.73e-05	5.41e-05	CcSEcCtD
Alprazolam—Dermatitis—Epirubicin—hematologic cancer	1.73e-05	5.4e-05	CcSEcCtD
Alprazolam—Headache—Epirubicin—hematologic cancer	1.72e-05	5.37e-05	CcSEcCtD
Alprazolam—Dizziness—Doxorubicin—hematologic cancer	1.68e-05	5.25e-05	CcSEcCtD
Alprazolam—Nausea—Epirubicin—hematologic cancer	1.63e-05	5.09e-05	CcSEcCtD
Alprazolam—Vomiting—Doxorubicin—hematologic cancer	1.61e-05	5.05e-05	CcSEcCtD
Alprazolam—Rash—Doxorubicin—hematologic cancer	1.6e-05	5e-05	CcSEcCtD
Alprazolam—Dermatitis—Doxorubicin—hematologic cancer	1.6e-05	5e-05	CcSEcCtD
Alprazolam—Headache—Doxorubicin—hematologic cancer	1.59e-05	4.97e-05	CcSEcCtD
Alprazolam—Nausea—Doxorubicin—hematologic cancer	1.51e-05	4.71e-05	CcSEcCtD
Alprazolam—CYP2C9—Metabolism—SMPD3—hematologic cancer	1.42e-05	0.00039	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GBA—hematologic cancer	1.42e-05	0.00039	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—SLC35B2—hematologic cancer	1.42e-05	0.00039	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	1.42e-05	0.000389	CbGpPWpGaD
Alprazolam—GABRB2—Transmission across Chemical Synapses—HRAS—hematologic cancer	1.41e-05	0.000388	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ARNTL—hematologic cancer	1.4e-05	0.000384	CbGpPWpGaD
Alprazolam—GABRA5—Transmission across Chemical Synapses—HRAS—hematologic cancer	1.37e-05	0.000377	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ACP5—hematologic cancer	1.36e-05	0.000374	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CA9—hematologic cancer	1.36e-05	0.000374	CbGpPWpGaD
Alprazolam—GABRA3—Transmission across Chemical Synapses—HRAS—hematologic cancer	1.35e-05	0.000371	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—NCOR2—hematologic cancer	1.34e-05	0.000369	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	1.34e-05	0.000367	CbGpPWpGaD
Alprazolam—GABRA2—Transmission across Chemical Synapses—HRAS—hematologic cancer	1.33e-05	0.000364	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	1.32e-05	0.000364	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—IL6—hematologic cancer	1.32e-05	0.000363	CbGpPWpGaD
Alprazolam—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	1.32e-05	0.000362	CbGpPWpGaD
Alprazolam—GABRB3—Transmission across Chemical Synapses—HRAS—hematologic cancer	1.32e-05	0.000362	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—MTAP—hematologic cancer	1.3e-05	0.000357	CbGpPWpGaD
Alprazolam—GABRG2—Transmission across Chemical Synapses—HRAS—hematologic cancer	1.29e-05	0.000355	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	1.29e-05	0.000355	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—IDH1—hematologic cancer	1.28e-05	0.000352	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ABCC3—hematologic cancer	1.27e-05	0.000348	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GSTO1—hematologic cancer	1.27e-05	0.000348	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—TXN—hematologic cancer	1.27e-05	0.000348	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.25e-05	0.000343	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—B3GAT1—hematologic cancer	1.24e-05	0.000341	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—DCK—hematologic cancer	1.24e-05	0.000341	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ASNS—hematologic cancer	1.24e-05	0.000341	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—SPHK1—hematologic cancer	1.24e-05	0.00034	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	1.23e-05	0.000337	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.21e-05	0.000334	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	1.21e-05	0.000333	CbGpPWpGaD
Alprazolam—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	1.21e-05	0.000333	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.19e-05	0.000328	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—UGT1A1—hematologic cancer	1.19e-05	0.000327	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—HDC—hematologic cancer	1.18e-05	0.000323	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.17e-05	0.000322	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—ALB—hematologic cancer	1.17e-05	0.000321	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.16e-05	0.00032	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CRABP1—hematologic cancer	1.16e-05	0.000318	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—SLC22A1—hematologic cancer	1.16e-05	0.000318	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—FHL2—hematologic cancer	1.16e-05	0.000318	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.14e-05	0.000314	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—ALB—hematologic cancer	1.14e-05	0.000312	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—AGRN—hematologic cancer	1.13e-05	0.000312	CbGpPWpGaD
Alprazolam—GABRA1—Transmission across Chemical Synapses—HRAS—hematologic cancer	1.13e-05	0.000311	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ALOX5—hematologic cancer	1.13e-05	0.00031	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—ALB—hematologic cancer	1.12e-05	0.000307	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	1.1e-05	0.000301	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—ALB—hematologic cancer	1.1e-05	0.000301	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—NUP98—hematologic cancer	1.09e-05	0.0003	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—ALB—hematologic cancer	1.09e-05	0.000299	CbGpPWpGaD
Alprazolam—GABRB2—Neuronal System—HRAS—hematologic cancer	1.08e-05	0.000298	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CDA—hematologic cancer	1.08e-05	0.000296	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—IDH2—hematologic cancer	1.08e-05	0.000296	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—HMMR—hematologic cancer	1.08e-05	0.000296	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—ALB—hematologic cancer	1.07e-05	0.000294	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ADCY7—hematologic cancer	1.06e-05	0.000291	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—NCOA3—hematologic cancer	1.06e-05	0.000291	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—NUP214—hematologic cancer	1.05e-05	0.000289	CbGpPWpGaD
Alprazolam—GABRA5—Neuronal System—HRAS—hematologic cancer	1.05e-05	0.000289	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PC—hematologic cancer	1.04e-05	0.000285	CbGpPWpGaD
Alprazolam—GABRA3—Neuronal System—HRAS—hematologic cancer	1.03e-05	0.000284	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—MTR—hematologic cancer	1.03e-05	0.000283	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ABCG2—hematologic cancer	1.03e-05	0.000283	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PHYH—hematologic cancer	1.02e-05	0.000281	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GMPS—hematologic cancer	1.02e-05	0.000281	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—FTCD—hematologic cancer	1.02e-05	0.000281	CbGpPWpGaD
Alprazolam—GABRA2—Neuronal System—HRAS—hematologic cancer	1.02e-05	0.000279	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ENO2—hematologic cancer	1.01e-05	0.000278	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ARNTL—hematologic cancer	1.01e-05	0.000278	CbGpPWpGaD
Alprazolam—GABRB3—Neuronal System—HRAS—hematologic cancer	1.01e-05	0.000277	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GBA—hematologic cancer	1e-05	0.000275	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—SLC35B2—hematologic cancer	1e-05	0.000275	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	9.99e-06	0.000274	CbGpPWpGaD
Alprazolam—GABRG2—Neuronal System—HRAS—hematologic cancer	9.91e-06	0.000272	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ACP5—hematologic cancer	9.84e-06	0.00027	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CA9—hematologic cancer	9.84e-06	0.00027	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GSTT1—hematologic cancer	9.81e-06	0.00027	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—NCOR2—hematologic cancer	9.71e-06	0.000267	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—SDC1—hematologic cancer	9.59e-06	0.000263	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—SMPD3—hematologic cancer	9.37e-06	0.000257	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—ALB—hematologic cancer	9.35e-06	0.000257	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—IDH1—hematologic cancer	9.25e-06	0.000254	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—MTAP—hematologic cancer	9.15e-06	0.000251	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—TXN—hematologic cancer	9.15e-06	0.000251	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ABCC3—hematologic cancer	9.15e-06	0.000251	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GSTO1—hematologic cancer	9.15e-06	0.000251	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—SPHK1—hematologic cancer	8.95e-06	0.000246	CbGpPWpGaD
Alprazolam—GABRA1—Neuronal System—HRAS—hematologic cancer	8.66e-06	0.000238	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—UGT1A1—hematologic cancer	8.6e-06	0.000236	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CRABP1—hematologic cancer	8.36e-06	0.00023	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—SLC22A1—hematologic cancer	8.36e-06	0.00023	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—DCK—hematologic cancer	8.19e-06	0.000225	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—B3GAT1—hematologic cancer	8.19e-06	0.000225	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ASNS—hematologic cancer	8.19e-06	0.000225	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—FHL2—hematologic cancer	8.16e-06	0.000224	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CD44—hematologic cancer	8.15e-06	0.000224	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—NQO1—hematologic cancer	8.15e-06	0.000224	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ALOX5—hematologic cancer	8.15e-06	0.000224	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—AGRN—hematologic cancer	8e-06	0.00022	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—NUP98—hematologic cancer	7.89e-06	0.000217	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—HDC—hematologic cancer	7.76e-06	0.000213	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CYCS—hematologic cancer	7.71e-06	0.000212	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—HSP90AA1—hematologic cancer	7.67e-06	0.000211	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—NCOA3—hematologic cancer	7.66e-06	0.000211	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ADCY7—hematologic cancer	7.66e-06	0.000211	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—NUP214—hematologic cancer	7.61e-06	0.000209	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—HMMR—hematologic cancer	7.58e-06	0.000208	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—IDH2—hematologic cancer	7.58e-06	0.000208	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—MTR—hematologic cancer	7.46e-06	0.000205	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ABCG2—hematologic cancer	7.46e-06	0.000205	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ENO2—hematologic cancer	7.31e-06	0.000201	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	7.15e-06	0.000196	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ARNTL—hematologic cancer	7.13e-06	0.000196	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CDA—hematologic cancer	7.1e-06	0.000195	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GSTT1—hematologic cancer	7.09e-06	0.000195	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CA9—hematologic cancer	6.93e-06	0.000191	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ACP5—hematologic cancer	6.93e-06	0.000191	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—SDC1—hematologic cancer	6.93e-06	0.00019	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—NCOR2—hematologic cancer	6.84e-06	0.000188	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PC—hematologic cancer	6.83e-06	0.000188	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GSTP1—hematologic cancer	6.8e-06	0.000187	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GBA—hematologic cancer	6.6e-06	0.000181	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—SLC35B2—hematologic cancer	6.6e-06	0.000181	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—IDH1—hematologic cancer	6.52e-06	0.000179	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GSTO1—hematologic cancer	6.45e-06	0.000177	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ABCC3—hematologic cancer	6.45e-06	0.000177	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—TXN—hematologic cancer	6.45e-06	0.000177	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ABCB1—hematologic cancer	6.44e-06	0.000177	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—SPHK1—hematologic cancer	6.31e-06	0.000173	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—NCOR1—hematologic cancer	6.25e-06	0.000172	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GSTM1—hematologic cancer	6.25e-06	0.000172	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—UGT1A1—hematologic cancer	6.06e-06	0.000167	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—MTAP—hematologic cancer	6.03e-06	0.000166	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CRABP1—hematologic cancer	5.9e-06	0.000162	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—SLC22A1—hematologic cancer	5.9e-06	0.000162	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CD44—hematologic cancer	5.89e-06	0.000162	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—NQO1—hematologic cancer	5.89e-06	0.000162	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ALOX5—hematologic cancer	5.75e-06	0.000158	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CYCS—hematologic cancer	5.58e-06	0.000153	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—NUP98—hematologic cancer	5.57e-06	0.000153	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—HSP90AA1—hematologic cancer	5.54e-06	0.000152	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—MTHFR—hematologic cancer	5.52e-06	0.000152	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ADCY7—hematologic cancer	5.4e-06	0.000148	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—NCOA3—hematologic cancer	5.4e-06	0.000148	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—FHL2—hematologic cancer	5.38e-06	0.000148	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—NUP214—hematologic cancer	5.36e-06	0.000147	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	5.31e-06	0.000146	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—AGRN—hematologic cancer	5.27e-06	0.000145	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—MTR—hematologic cancer	5.26e-06	0.000144	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ABCG2—hematologic cancer	5.26e-06	0.000144	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ENO2—hematologic cancer	5.15e-06	0.000142	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—IDH2—hematologic cancer	5e-06	0.000137	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—HMMR—hematologic cancer	5e-06	0.000137	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GSTT1—hematologic cancer	5e-06	0.000137	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.92e-06	0.000135	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GSTP1—hematologic cancer	4.92e-06	0.000135	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—SDC1—hematologic cancer	4.89e-06	0.000134	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ARNTL—hematologic cancer	4.7e-06	0.000129	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.67e-06	0.000128	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ABCB1—hematologic cancer	4.65e-06	0.000128	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PIK3CG—hematologic cancer	4.64e-06	0.000128	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.61e-06	0.000127	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ACP5—hematologic cancer	4.57e-06	0.000126	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CA9—hematologic cancer	4.57e-06	0.000126	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GSTM1—hematologic cancer	4.52e-06	0.000124	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—NCOR1—hematologic cancer	4.52e-06	0.000124	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—NCOR2—hematologic cancer	4.51e-06	0.000124	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.41e-06	0.000121	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CREBBP—hematologic cancer	4.3e-06	0.000118	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—IDH1—hematologic cancer	4.3e-06	0.000118	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GSTO1—hematologic cancer	4.25e-06	0.000117	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—TXN—hematologic cancer	4.25e-06	0.000117	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ABCC3—hematologic cancer	4.25e-06	0.000117	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—SPHK1—hematologic cancer	4.16e-06	0.000114	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CD44—hematologic cancer	4.15e-06	0.000114	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—NQO1—hematologic cancer	4.15e-06	0.000114	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PIK3CD—hematologic cancer	4.08e-06	0.000112	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.07e-06	0.000112	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ALB—hematologic cancer	4.03e-06	0.000111	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—UGT1A1—hematologic cancer	4e-06	0.00011	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—MTHFR—hematologic cancer	3.99e-06	0.00011	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CYCS—hematologic cancer	3.93e-06	0.000108	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	3.91e-06	0.000107	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—SLC22A1—hematologic cancer	3.89e-06	0.000107	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CRABP1—hematologic cancer	3.89e-06	0.000107	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PIK3R1—hematologic cancer	3.85e-06	0.000106	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ALOX5—hematologic cancer	3.79e-06	0.000104	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—NUP98—hematologic cancer	3.67e-06	0.000101	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ADCY7—hematologic cancer	3.56e-06	9.79e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—NCOA3—hematologic cancer	3.56e-06	9.79e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PIK3CB—hematologic cancer	3.56e-06	9.77e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—NUP214—hematologic cancer	3.54e-06	9.72e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.52e-06	9.66e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—MTR—hematologic cancer	3.47e-06	9.52e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ABCG2—hematologic cancer	3.47e-06	9.52e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GSTP1—hematologic cancer	3.47e-06	9.52e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ENO2—hematologic cancer	3.4e-06	9.34e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PIK3CG—hematologic cancer	3.35e-06	9.22e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.35e-06	9.21e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GSTT1—hematologic cancer	3.3e-06	9.06e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ABCB1—hematologic cancer	3.28e-06	9.01e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—SDC1—hematologic cancer	3.22e-06	8.85e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GSTM1—hematologic cancer	3.18e-06	8.75e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—NCOR1—hematologic cancer	3.18e-06	8.75e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CREBBP—hematologic cancer	3.11e-06	8.55e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PTEN—hematologic cancer	3.07e-06	8.44e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PIK3CD—hematologic cancer	2.95e-06	8.1e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—EP300—hematologic cancer	2.93e-06	8.05e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ALB—hematologic cancer	2.91e-06	8e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—MTHFR—hematologic cancer	2.81e-06	7.73e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PIK3R1—hematologic cancer	2.78e-06	7.65e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CD44—hematologic cancer	2.74e-06	7.53e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—NQO1—hematologic cancer	2.74e-06	7.53e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CYCS—hematologic cancer	2.59e-06	7.12e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.58e-06	7.08e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PIK3CB—hematologic cancer	2.57e-06	7.06e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.48e-06	6.81e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PIK3CG—hematologic cancer	2.36e-06	6.5e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.29e-06	6.28e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PTEN—hematologic cancer	2.22e-06	6.1e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CREBBP—hematologic cancer	2.19e-06	6.02e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PIK3CA—hematologic cancer	2.17e-06	5.96e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.16e-06	5.94e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—EP300—hematologic cancer	2.12e-06	5.82e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.1e-06	5.77e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.1e-06	5.77e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PIK3CD—hematologic cancer	2.08e-06	5.71e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ALB—hematologic cancer	2.05e-06	5.64e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PIK3R1—hematologic cancer	1.96e-06	5.39e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.86e-06	5.1e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.81e-06	4.98e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—AKT1—hematologic cancer	1.77e-06	4.87e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PIK3CA—hematologic cancer	1.57e-06	4.31e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PTEN—hematologic cancer	1.57e-06	4.3e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.56e-06	4.28e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—EP300—hematologic cancer	1.49e-06	4.1e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.45e-06	3.97e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.37e-06	3.77e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ALB—hematologic cancer	1.35e-06	3.72e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.29e-06	3.56e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—AKT1—hematologic cancer	1.28e-06	3.52e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.19e-06	3.28e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PIK3CA—hematologic cancer	1.1e-06	3.03e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PTEN—hematologic cancer	1.03e-06	2.84e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—EP300—hematologic cancer	9.85e-07	2.71e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—AKT1—hematologic cancer	9.02e-07	2.48e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PIK3CA—hematologic cancer	7.28e-07	2e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—AKT1—hematologic cancer	5.95e-07	1.64e-05	CbGpPWpGaD
